0001596771-18-000086.txt : 20180724 0001596771-18-000086.hdr.sgml : 20180724 20180724115821 ACCESSION NUMBER: 0001596771-18-000086 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180724 DATE AS OF CHANGE: 20180724 EFFECTIVENESS DATE: 20180724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROONE MEDICAL TECHNOLOGIES Corp CENTRAL INDEX KEY: 0001500198 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 270863354 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-317594 FILM NUMBER: 18965997 BUSINESS ADDRESS: STREET 1: 10006 LIATRIS LANE CITY: EDEN PRAIRIE STATE: MN ZIP: 55347 BUSINESS PHONE: (952) 237-7412 MAIL ADDRESS: STREET 1: 10006 LIATRIS LANE CITY: EDEN PRAIRIE STATE: MN ZIP: 55347 FORMER COMPANY: FORMER CONFORMED NAME: Original Source Entertainment, Inc. DATE OF NAME CHANGE: 20100830 D 1 primary_doc.xml X0708 D LIVE 0001500198 NEUROONE MEDICAL TECHNOLOGIES Corp 10006 LIATRIS LANE EDEN PRAIRIE MN MINNESOTA 55347 (952) 237-7412 DELAWARE Original Source Entertainment, Inc. Corporation true David A. Rosa 10006 Liatris Lane Eden Prairie MN MINNESOTA 55347 Executive Officer Director Thomas Bachinski 19059 Orchard Trail Lakeville MN MINNESOTA 55044 Executive Officer Mark Christianson 10006 Liatris Lane Eden Prairie MN MINNESOTA 55347 Executive Officer Paul Buckman 10006 Liatris Lane Eden Prairie MN MINNESOTA 55347 Director Suraj Kalia 10006 Liatris Lane Eden Prairie MN MINNESOTA 55347 Director Jeffrey S. Mathiesen 10006 Liatris Lane Eden Prairie MN MINNESOTA 55347 Director Biotechnology Decline to Disclose 06b false 2018-07-09 false true true true false 0 10000000 538000 9462000 Over-allotment amount of $1,500,000 false 4 1000000 true 0 In addition to a cash commission of 10% of the gross proceeds from the offering, the brokers will receive warrants to purchase an amount of common stock equal to 10% of the total amount of shares sold in the offering. 823140 true The proceeds of this private placement, along with proceeds from other financings, may be used to pay certain executive officers. false NEUROONE MEDICAL TECHNOLOGIES Corp /s/ David A. Rosa David A. Rosa CEO 2018-07-24